Is AVRO or DVY a better dividend investment in 2026?

AVRO currently yields 142.86% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: AVRO offers higher current income.

What is the dividend yield difference between AVRO and DVY?

AVRO has a forward dividend yield of 142.86% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 139.36 percentage points.

Home › Compare › AVRO vs DVY

AVRO vs DVY: Dividend Comparison 2026

AVRO yields 142.86% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVRO wins by $19.53M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVRO

● Live price

142.86%

Share price

$1.40

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$19.55M

Annual income

$8,225,014.26

Full AVRO calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — AVRO vs DVY

📍 AVRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVRO	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVRO + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVRO pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVRO

Annual income on $10K today (after 15% tax)

$12,142.86/yr

After 10yr DRIP, annual income (after tax)

$6,991,262.12/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, AVRO beats the other by $6,990,890.01/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVRO + DVY for your $10,000?

AVRO: 50%DVY: 50%

100% DVY50/50100% AVRO

Portfolio after 10yr

$9.79M

Annual income

$4,112,726.02/yr

Blended yield

42.02%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVRO buys

DVY buys

No recent congressional trades found for AVRO or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVRODVY

Forward yield	142.86% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$19.55M	$25.1K ✓
Annual income after 10y	$8,225,014.26 ✓	$437.78
Total dividends collected	$18.03M ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AVRO vs DVY ($10,000, DRIP)

Year	AVRO Portfolio	AVRO Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$24,986	$14,285.71	$11,050	$349.62	+$13.9K → AVRO
2	$60,093	$33,358.76	$12,184	$361.04	+$47.9K → AVRO
3	$139,283	$74,982.82	$13,409	$372.07	+$125.9K → AVRO
4	$311,456	$162,423.26	$14,730	$382.68	+$296.7K → AVRO
5	$672,698	$339,440.31	$16,154	$392.89	+$656.5K → AVRO
6	$1,404,965	$685,177.81	$17,688	$402.69	+$1.39M → AVRO
7	$2,840,723	$1,337,410.52	$19,338	$412.07	+$2.82M → AVRO
8	$5,566,801	$2,527,227.75	$21,113	$421.04	+$5.55M → AVRO
9	$10,584,947	$4,628,469.98	$23,020	$429.61	+$10.56M → AVRO
10	$19,550,908	$8,225,014.26	$25,070	$437.78	+$19.53M → AVRO

AVRO vs DVY: Complete Analysis 2026

AVRO — Stock

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Full AVRO Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this AVRO vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVRO vs SCHD AVRO vs JEPI AVRO vs O AVRO vs KO AVRO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.